 42 citations
,
  July 2021   in “Frontiers in Medicine”
           42 citations
,
  July 2021   in “Frontiers in Medicine”    Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.  
      41 citations
,
  February 2021   in “Cureus”
           41 citations
,
  February 2021   in “Cureus”    Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.  
      19 citations
,
  December 2021   in “Cureus”
           19 citations
,
  December 2021   in “Cureus”    Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.  
      5 citations
,
  July 2021   in “medRxiv (Cold Spring Harbor Laboratory)”
           5 citations
,
  July 2021   in “medRxiv (Cold Spring Harbor Laboratory)”    Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.  
      5 citations
,
  July 2021   in “medRxiv (Cold Spring Harbor Laboratory)”
           5 citations
,
  July 2021   in “medRxiv (Cold Spring Harbor Laboratory)”    Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.